-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
412
，8
410，、、、、、、、8。
49，《》，2021430。
，，40mg，，。，430。
、、，。
，430——，，（）2，。
48，《》，202151。
，（）（），，，（），。
42，《》。
，2021428，、，。
46，pharmnet.
com.
cn/news/yyzb/" target="_blank">《（）》，。
com.
cn/news/yyzb/" target="_blank">《（）》，。
，（）2021428。420，。
：
，，50（；1；），（），（CA）“”，，。
Enterprises must ensure that each selected product has a distribution relationship across the province, and that the selected distribution company can deliver the selected product to medical institutions in the province.
Build time.
April 7 to April 13, 2021.
Build time.
April 7 to April 13, 2021.
Signing method.
All medical and health institutions and selected enterprises sign online purchase and sale agreements through the Zhejiang Pharmaceutical Equipment Procurement Platform.
The medical and health institutions and the selected enterprises log in to the Zhejiang Pharmaceutical Equipment Purchasing Platform through their user accounts to complete the signing of the purchase and sale agreement by confirming the agreement.
The online confirmation of the agreement between the two parties is deemed to be the signing of the purchase and sale agreement.
All medical and health institutions and selected enterprises sign online purchase and sale agreements through the Zhejiang Pharmaceutical Equipment Procurement Platform.
The medical and health institutions and the selected enterprises log in to the Zhejiang Pharmaceutical Equipment Purchasing Platform through their user accounts to complete the signing of the purchase and sale agreement by confirming the agreement.
The online confirmation of the agreement between the two parties is deemed to be the signing of the purchase and sale agreement.
Signing time.
April 9 to April 15, 2021.
The system will be open from 9:00 on April 9, 2021 to 16:00 on April 15, 2021.
April 9 to April 15, 2021.
The system will be open from 9:00 on April 9, 2021 to 16:00 on April 15, 2021.
Shanxi
On March 30, the Shanxi Medical Insurance Bureau issued the "Notice on Fully Implementing the Fourth Batch of National Organizations for the Centralized Procurement and Use of Drugs", stating that all medical institutions in Shanxi Province participating in this centralized procurement will implement the implementation on May 1, 2021.
The results of the fourth batch of national joint procurement office cloths.
The results of the fourth batch of national joint procurement office cloths.
The selected drugs are independently commissioned by the selected companies to distribute them by reputable distribution companies with distribution capabilities or on their own.
In principle, 3-5 distribution companies are selected in each coordinating area, and the distribution must cover all medical institutions participating in mass procurement.
In principle, 3-5 distribution companies are selected in each coordinating area, and the distribution must cover all medical institutions participating in mass procurement.
Henan
On March 26, the Henan Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organizations for the Implementation of Centralized Procurement of Drugs".
It is clear that the fourth batch of national centralized procurement will be implemented before April 30, 2021.
The result of the selection of the product specification.
It is clear that the fourth batch of national centralized procurement will be implemented before April 30, 2021.
The result of the selection of the product specification.
Prior to April 16th, the selected companies will do a good job in maintaining the qualifications of the selected companies and maintaining the information of the selected products.
At the same time, we will select an operating company with distribution capability and good reputation to distribute the selected drugs, and establish a distribution relationship.
At the same time, we will select an operating company with distribution capability and good reputation to distribute the selected drugs, and establish a distribution relationship.
Before April 23, medical institutions, selected enterprises , and operating companies log on to the provincial pharmaceutical procurement platform and confirm the three-party purchase and sale contract before the pharmaceutical institution can proceed with platform procurement.
Starting from April 26, the Henan Provincial Public Resource Trading Center will uniformly adjust the prices of related drugs.
Medical insurance departments at all levels supervise and urge medical institutions within their jurisdiction to purchase the selected drugs in a timely manner at the selected price to ensure that patients in Henan Province can purchase the selected drugs at the selected price on April 30.
Medical insurance departments at all levels supervise and urge medical institutions within their jurisdiction to purchase the selected drugs in a timely manner at the selected price to ensure that patients in Henan Province can purchase the selected drugs at the selected price on April 30.
Ningxia
On March 25, the Ningxia Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organized Drug Centralized Procurement", which clarified that according to the results and work requirements of the fourth batch of nationally organized drug centralized procurement, it is scheduled for May 2021 Implementation on the 20th.
Before April 20, complete the CA certificate application and log in to the Ningxia Pharmaceutical Procurement Platform to sign the purchase and sales contract; before May 18, complete the signing of the purchase and sales agreement; and officially implement the fourth batch of national organization drug procurement results in Ningxia on May 20.
Jiangsu
On March 19, the Jiangsu Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement Results", which officially determined the launch time of the fourth batch of nationally selected results in Jiangsu Province.
According to the notice, all public medical institutions and military medical institutions in Jiangsu Province will start to implement the fourth batch of procurement products announced by the National Procurement and the results of the selection from April 27, 2021.
Liaoning
On March 2, the Liaoning Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in Preparations for the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement (Liaoning) Results".
From 0:00 on May 1st, Liaoning Province will implement the fourth batch of national Collect the results of the selection in Liaoning.
From 0:00 on May 1st, Liaoning Province will implement the fourth batch of national Collect the results of the selection in Liaoning.
According to the schedule of Liaoning Province:
Before April 20th, the municipal medical insurance bureaus will organize medical institutions to complete the signing of bulk purchase contracts for drug production (business) enterprises.
Before April 20th, the medical insurance agencies of each city shall calculate the prepaid working capital according to the agreed purchase amount of the medical institution (the prepaid working capital shall be allocated to the medical institution in areas where the direct settlement of the medical insurance fund is not implemented).
Before April 30, the relevant selected drugs will be prepared in advance to the relevant medical institutions.
21 provinces and cities issued the fourth batch of national procurement notices
According to Cyberlan’s latest review, in addition to the above eight provinces, Yunnan, Anhui, Guangdong, Shaanxi, Hunan, Ningxia, Tibet, Sichuan, Hainan, Hubei, Shanghai, Gansu, Jiangxi, Tianjin, Jilin, Beijing, Qinghai, Inner Mongolia, The 21 provinces and cities of Fujian, Xinjiang, and Guangxi have also issued relevant notices on the results of the fourth batch of national selection.
According to official sources, the fourth batch of centralized procurement of drugs is expected to land around May.
At present, 29 provinces and cities have issued relevant documents on the implementation of the fourth batch of national procurement.
It is believed that as May approaches, the remaining regions will also The announcement of the fourth batch of relevant announcements on the results of the national procurement selection.
At present, 29 provinces and cities have issued relevant documents on the implementation of the fourth batch of national procurement.
It is believed that as May approaches, the remaining regions will also The announcement of the fourth batch of relevant announcements on the results of the national procurement selection.
At present, the notices in the 8 provinces and cities of Inner Mongolia, Beijing, Fujian, Xinjiang, Guangxi, Tibet, Qinghai, and Yunnan are still within the statute of limitations.
Although these notices do not specify the execution time of the results, the online procurement and contract signing before the results are implemented The work has been arranged, and I believe that the final landing is close at hand.
Although these notices do not specify the execution time of the results, the online procurement and contract signing before the results are implemented The work has been arranged, and I believe that the final landing is close at hand.
Inner Mongolia
On April 9, the Inner Mongolia Autonomous Region Pharmaceutical Purchasing Network issued the "Notice on Publicizing the Review Results of Inner Mongolia Autonomous Region's Drug Centralized Online Work (Fourth Batch)", and announced the fourth batch of drug information review results.
The publicity period is April 2021.
9th-April 15th.
The publicity period is April 2021.
9th-April 15th.
According to the notice, the participating companies log in [Inner Mongolia Autonomous Region Drug Centralized Procurement System]-[Assessment System]-[Audit Result Disclosure List] to view relevant drug information audit results with their username and password.
Beijing
On April 9, Beijing Municipal Pharmaceutical Centralized Purchasing Service Center issued the "Notice on Carrying out the Supply List of Selected Varieties in the Fourth Batch of State-Organized Pharmaceutical Centralized Purchasing and Confirmation of Distributors"
In accordance with Beijing's implementation of the fourth batch of nationally organized drug procurement and use related requirements, Beijing will soon carry out the supply list of relevant selected varieties and the confirmation of distributors.
The fourth batch of state-organized pharmaceutical manufacturing companies that use centralized procurement of drugs and use the selected varieties in Beijing will log in to the Beijing Pharmaceutical Sunshine Procurement Platform and perform confirmation operations in accordance with the relevant operating manuals.
Manufacturers of selected products need to complete the confirmation of supply products and distributors in the system on April 9-15, 2021.
They belong to the fourth batch of nationally announced drugs to organize centralized procurement of drugs.
The selected specifications and packaging products of national drugs are required products.
.
They belong to the fourth batch of nationally announced drugs to organize centralized procurement of drugs.
The selected specifications and packaging products of national drugs are required products.
.
Manufacturers should log in to the Sunshine Pharmaceuticals Purchasing Platform in a timely manner, and complete the signing and termination of the contract with the delivery company in accordance with the confirmed supply products.
Manufacturers should truthfully confirm the supply of products and distributors, and ensure that they can supply Beijing medical institutions in a timely and sufficient manner through confirmed distributors.
For products with unconfirmed distributors that expire, the platform will treat them as non-supplied products and suspend purchases.
For products with unconfirmed distributors that expire, the platform will treat them as non-supplied products and suspend purchases.
After this confirmation, the Beijing Municipal Pharmaceutical Centralized Purchasing Service Center will publicize the selected product supply list and the results of the distributors confirmed by each manufacturer, so that each medical institution can choose to purchase.
Fujian
On April 8, the Fujian Medical Insurance Bureau issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Related Drugs Online" The relevant matters are notified as follows:
After the fourth batch of national-organized centralized drug procurement is selected, the drugs in the list of products supplied by Fujian will start to declare their products from April 9 to 13, 2021.
The notice gives different declaration paths for drugs that have been listed on the Internet in Fujian Province and those that have not been listed on the Internet in Fujian Province:
(1) For drugs that have been listed on the Internet catalogue in Fujian Province, the online maintenance and price confirmation are carried out through the "Internet status and price dynamic adjustment" module of the Fujian Pharmaceutical Machinery Joint Price-Limiting Sunshine Procurement Platform.
(2) For drugs that are not listed on the Fujian Provincial Internet Catalog, fill in and upload relevant supporting documents through the "Enterprise Basic Information Application" and "Product Basic Information Application" modules of the Fujian Pharmaceutical Equipment Joint Price-Limiting Sunshine Procurement Platform.
After the basic information is declared, Apply for listing and price declaration through the platform "Network Link Status and Price Dynamic Adjustment" module.
After the basic information is declared, Apply for listing and price declaration through the platform "Network Link Status and Price Dynamic Adjustment" module.
Xinjiang
On April 6, the drug procurement management platform for medical institutions in Xinjiang issued the "Notice on Starting the Preparation Work for the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected in the Internet".
The notice requires that among the selected products, those manufacturing and operating companies that are not registered on the drug procurement management platform of Xinjiang medical institutions shall, in accordance with the requirements of the "Notice on the Implementation of the Work Related to the Implementation of the Autonomous Region’s Drug Price and Recruitment Credit Evaluation System," After the platform uploads the letter of commitment to keep promises, it then submits the materials to apply for the enterprise user name, and finally applies for the digital certificate.
From the date of publication of the notice, relevant companies can begin relevant operations.
From the date of publication of the notice, relevant companies can begin relevant operations.
All relevant drug manufacturers and operating (distributing) companies can log in to the "Autonomous Region Medical Institution Drug Centralized Purchase Transaction System" from April 6 to start maintaining and confirming the drug distribution relationship.
The relevant drug manufacturers and operating (distribution) companies are requested to complete the determination of the distribution relationship of the selected drugs before April 15, 2021.
The Autonomous Region Medical Institutions’ Drug Centralized Procurement Transaction System will start the tripartite contract function for selected drugs on April 20.
Medical institutions, drug manufacturers, and business (distribution) companies are requested to complete the tripartite contract as soon as possible so that online transactions can be carried out on time.
.
Medical institutions, drug manufacturers, and business (distribution) companies are requested to complete the tripartite contract as soon as possible so that online transactions can be carried out on time.
.
Guangxi
On April 6, the procurement service platform of Guangxi Pharmaceutical Group issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Guangxi Selected Drugs".
The fourth batch of national-organized centralized drug procurement in Guangxi selected drugs in accordance with the "National Drug Centralization List of products to be supplied after selection in procurement)" The selected price and specifications and packaging information are directly posted online.
The fourth batch of national-organized centralized drug procurement in Guangxi selected drugs in accordance with the "National Drug Centralization List of products to be supplied after selection in procurement)" The selected price and specifications and packaging information are directly posted online.
Related pharmaceutical companies log on to the Guangxi Pharmaceutical Group Procurement Service Platform before April 12, maintain corporate information, product information, and price information in accordance with platform requirements, complete information filling and upload qualification documents.
At the same time, relevant pharmaceutical manufacturers are requested to independently select distribution companies with distribution capabilities and good reputation on the platform to prepare for the establishment of distribution relationships.
Tibet
The Tibet Autonomous Region Drug Purchasing Service Management Center issued the "Notice on Convening the Fourth Batch of National Organizations for Centralized Drug Purchasing and the "Six Provinces and Two Districts" Inter-provincial Union Drug Centralized Procurement Work Meeting", stating that the fourth batch of national organizations is planned to be held in Lhasa.
The deployment meeting for centralized drug procurement and the implementation of selected products in the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Meeting time: April 13, 2021, from 10:00 to 13:00.
The deployment meeting for centralized drug procurement and the implementation of selected products in the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Meeting time: April 13, 2021, from 10:00 to 13:00.
At that time, the meeting will make specific arrangements for the fourth batch of national centralized drug procurement and the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Qinghai
On April 2, the Qinghai Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Related to the Internet", which clarified that the same category of drugs has passed the consistency evaluation of more than 3 (including 3), no more listing of generic drugs that have not passed the consistency evaluation.
Selected and non-selected drugs that have won the bid (linked to the Internet) in Qinghai Province, and related companies have registered for centralized trading of drugs and medical consumables-"Data reporting in the drug trading system-the fourth batch of national selected drugs price declaration and the fourth batch of national non-selected drugs The price declaration module carries out price declaration separately.
For products that are not listed on the Qinghai Province, relevant companies log on to the Qinghai Province Drug and Medical Consumables Centralized Procurement Network to apply for the fourth batch of nationally organized drugs for centralized procurement of selected drugs and non-selected drugs.
(1) Corporate information maintenance and price declaration time: April 2, 2021 to April 12, 2021.
(2) Confirmation time of the selected drug distribution relationship: before 18:00 on April 15, 2021.
(3) The application information of non-selected drugs will be publicized and will be posted on the Internet if they meet the requirements, and the time for the selection and confirmation of the distribution relationship will be notified separately.
Yunnan
On March 26, the Yunnan Provincial Drug Centralized Procurement Platform issued the "Notice on the Issues Concerning the Online Transactions of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected" clarified that the results of the fourth batch of nationally organized centralized drug procurement in Yunnan correspond to the list of supply varieties For the drugs with the remarks "sample registration required", the sample registration work will begin immediately.
Enterprises are required to complete the sample registration according to the prescribed procedures.
Enterprises are required to complete the sample registration according to the prescribed procedures.
After the enterprise completes the sample filing, before 17:00 on April 15, 2021 (except statutory holidays), the Yunnan Provincial Drug Administration will stamp the "Yunnan Province Essential Drugs Bid Sample Recording Form" and the "Statutory Representative Authorization Letter", the original scanned and sent to the e-mail: ynsypjzcgpt@163.
com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
The final online transaction time will be notified separately.
A few days ago, relevant industry media reported that for the fifth batch of national sources, the current varieties have met the start-up requirements, and the fifth batch of national sources is in the pipeline.
According to past laws, as the fourth batch of national procurement is implemented nationwide, a new round of centralized procurement may be on the way.
According to past laws, as the fourth batch of national procurement is implemented nationwide, a new round of centralized procurement may be on the way.
Medical Network News on April 12
The fourth batch of national procurement, 8 provinces specify the implementation time
According to Cyberlan's analysis on April 10, 8 provinces of Liaoning, Jiangsu, Ningxia, Henan, Shanxi, Zhejiang, Guizhou, and Heilongjiang have determined the implementation time of the fourth batch of national procurement.
Guizhou
On April 9, the Guizhou Province Pharmaceutical Centralized Procurement Platform issued the "Guizhou Province’s Notice on Implementing the Fourth Batch of National Organizations for Centralized Drug Procurement Work", clarifying that Guizhou Province will implement the fourth batch of national procurement from April 30, 2021.
Winning result.
Winning result.
It is worth noting that Guizhou Province proposed that 40 mg of pantoprazole sodium for injection will be implemented according to the results of the five provinces and cities, and the national election results will be implemented the following year.
The selected price of this product, Jiangsu Aosaikang Pharmaceutical Co.
, Ltd.
and Yangtze River Pharmaceutical Group Co.
, Ltd.
, selected in five provinces and cities, will be adjusted and implemented according to the national selected price from April 30.
The selected price of this product, Jiangsu Aosaikang Pharmaceutical Co.
, Ltd.
and Yangtze River Pharmaceutical Group Co.
, Ltd.
, selected in five provinces and cities, will be adjusted and implemented according to the national selected price from April 30.
Regarding the conflicts between the centralized procurement of inter-provincial alliances and the centralized procurement of drugs organized by the state, the results of the selection, and the prices of the selection, Guizhou Province has given the above-mentioned measures.
Guizhou Province requires selected companies to establish distribution relationships on the platform in advance, and medical institutions will place orders for purchases from April 30th.
In order to ensure the supply of selected products, the selected companies independently entrust companies with excellent distribution performance to establish distribution relationships.
There are no less than 2 cities (states), and the distribution area can cover all medical institutions participating in mass procurement.
In order to ensure the supply of selected products, the selected companies independently entrust companies with excellent distribution performance to establish distribution relationships.
There are no less than 2 cities (states), and the distribution area can cover all medical institutions participating in mass procurement.
Heilongjiang
On April 8, the Heilongjiang Provincial Drug Centralized Procurement Network issued the "Notice on Doing a Good Job in the Implementation of the National and Inter-provincial Alliance Drug Centralized Procurement of Drugs".
It is clear that the fourth batch of nationally organized drug procurement in Heilongjiang will be selected from May 1, 2021.
It will be implemented throughout the province starting from today.
It is clear that the fourth batch of nationally organized drug procurement in Heilongjiang will be selected from May 1, 2021.
It will be implemented throughout the province starting from today.
The notice requires that all municipal (prefecture) medical insurance bureaus should organize the contract signing between public medical institutions in their jurisdictions and selected manufacturing enterprises (distributors with distribution qualifications independently selected by the selected manufacturing enterprises), and sign purchase and sales contracts in a manner recognized by both parties.
To confirm the purchase volume and total purchase amount, each municipal (prefecture) medical insurance bureau shall supervise and urge relevant medical institutions to complete the contract purchase quantity and proportion within the purchase cycle, and encourage medical institutions to more accurately submit basic data for the purchase of quantities.
To confirm the purchase volume and total purchase amount, each municipal (prefecture) medical insurance bureau shall supervise and urge relevant medical institutions to complete the contract purchase quantity and proportion within the purchase cycle, and encourage medical institutions to more accurately submit basic data for the purchase of quantities.
Zhejiang
On April 2, the Zhejiang Medical Insurance Bureau issued the "Announcement on the Implementation of the Results of the Fourth Batch of National Organizations for Centralized Procurement of Drugs" officially announced the implementation time of the fourth batch of national procurement results.
According to the announcement, the fourth batch of national procurement will be implemented in Zhejiang on April 28, 2021.
The scope of implementation is all public medical institutions, military medical institutions, and voluntary medical insurance designated social medical institutions and medical insurance designated retail stores in Zhejiang.
Pharmacy .
The scope of implementation is all public medical institutions, military medical institutions, and voluntary medical insurance designated social medical institutions and medical insurance designated retail stores in Zhejiang.
Pharmacy .
On April 6, the Zhejiang Pharmaceutical Equipment pharmnet.
com.
cn/news/yyzb/" target="_blank">Procurement Center issued the "Notice on Doing a Good Job in the Online Procurement of Selected Products in the Fourth Batch of National Organizations of Centralized Procurement of Drugs (Zhejiang)", requiring relevant companies to establish distribution relationships and sign purchase and sale agreements.
com.
cn/news/yyzb/" target="_blank">Procurement Center issued the "Notice on Doing a Good Job in the Online Procurement of Selected Products in the Fourth Batch of National Organizations of Centralized Procurement of Drugs (Zhejiang)", requiring relevant companies to establish distribution relationships and sign purchase and sale agreements.
According to the above notice, the selection results of the fourth batch of nationally organized centralized drug procurement (Zhejiang) will be officially implemented on April 28, 2021.
The Zhejiang Pharmaceutical Equipment Procurement Platform will list the selected products on the Internet on April 20 for medical and health institutions to stock up first.
The Zhejiang Pharmaceutical Equipment Procurement Platform will list the selected products on the Internet on April 20 for medical and health institutions to stock up first.
The notice is clear:
The selected companies are selected from the qualified drug distribution companies in Zhejiang Province in accordance with the distribution companies’ promised distribution areas, and the total number shall not exceed 50 (manufacturing companies do not take up the quota for self-distribution; distribution companies with distribution capabilities across the province must reach 1 or more; Group-type distribution companies take the group as the selection object), after the two parties confirm the product distribution relationship in written form (with both parties’ seals), log in to the Zhejiang Pharmaceutical Equipment Procurement Platform "Enterprise" by mail or through a digital certificate (CA) "Material online declaration" system, upload and submit to Zhejiang Pharmaceutical Equipment Procurement Center, no need to submit on-site.
Enterprises must ensure that each selected product has a distribution relationship across the province, and that the selected distribution company can deliver the selected product to medical institutions in the province.
Build time.
April 7 to April 13, 2021.
Build time.
April 7 to April 13, 2021.
Signing method.
All medical and health institutions and selected enterprises sign online purchase and sale agreements through the Zhejiang Pharmaceutical Equipment Procurement Platform.
The medical and health institutions and the selected enterprises log in to the Zhejiang Pharmaceutical Equipment Purchasing Platform through their user accounts to complete the signing of the purchase and sale agreement by confirming the agreement.
The online confirmation of the agreement between the two parties is deemed to be the signing of the purchase and sale agreement.
All medical and health institutions and selected enterprises sign online purchase and sale agreements through the Zhejiang Pharmaceutical Equipment Procurement Platform.
The medical and health institutions and the selected enterprises log in to the Zhejiang Pharmaceutical Equipment Purchasing Platform through their user accounts to complete the signing of the purchase and sale agreement by confirming the agreement.
The online confirmation of the agreement between the two parties is deemed to be the signing of the purchase and sale agreement.
Signing time.
April 9 to April 15, 2021.
The system will be open from 9:00 on April 9, 2021 to 16:00 on April 15, 2021.
April 9 to April 15, 2021.
The system will be open from 9:00 on April 9, 2021 to 16:00 on April 15, 2021.
Shanxi
On March 30, the Shanxi Medical Insurance Bureau issued the "Notice on Fully Implementing the Fourth Batch of National Organizations for the Centralized Procurement and Use of Drugs", stating that all medical institutions in Shanxi Province participating in this centralized procurement will implement the implementation on May 1, 2021.
The results of the fourth batch of national joint procurement office cloths.
The results of the fourth batch of national joint procurement office cloths.
The selected drugs are independently commissioned by the selected companies to distribute them by reputable distribution companies with distribution capabilities or on their own.
In principle, 3-5 distribution companies are selected in each coordinating area, and the distribution must cover all medical institutions participating in mass procurement.
In principle, 3-5 distribution companies are selected in each coordinating area, and the distribution must cover all medical institutions participating in mass procurement.
Henan
On March 26, the Henan Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organizations for the Implementation of Centralized Procurement of Drugs".
It is clear that the fourth batch of national centralized procurement will be implemented before April 30, 2021.
The result of the selection of the product specification.
It is clear that the fourth batch of national centralized procurement will be implemented before April 30, 2021.
The result of the selection of the product specification.
Prior to April 16th, the selected companies will do a good job in maintaining the qualifications of the selected companies and maintaining the information of the selected products.
At the same time, we will select an operating company with distribution capability and good reputation to distribute the selected drugs, and establish a distribution relationship.
At the same time, we will select an operating company with distribution capability and good reputation to distribute the selected drugs, and establish a distribution relationship.
Before April 23, medical institutions, selected enterprises , and operating companies log on to the provincial pharmaceutical procurement platform and confirm the three-party purchase and sale contract before the pharmaceutical institution can proceed with platform procurement.
Starting from April 26, the Henan Provincial Public Resource Trading Center will uniformly adjust the prices of related drugs.
Medical insurance departments at all levels supervise and urge medical institutions within their jurisdiction to purchase the selected drugs in a timely manner at the selected price to ensure that patients in Henan Province can purchase the selected drugs at the selected price on April 30.
Medical insurance departments at all levels supervise and urge medical institutions within their jurisdiction to purchase the selected drugs in a timely manner at the selected price to ensure that patients in Henan Province can purchase the selected drugs at the selected price on April 30.
Ningxia
On March 25, the Ningxia Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organized Drug Centralized Procurement", which clarified that according to the results and work requirements of the fourth batch of nationally organized drug centralized procurement, it is scheduled for May 2021 Implementation on the 20th.
Before April 20, complete the CA certificate application and log in to the Ningxia Pharmaceutical Procurement Platform to sign the purchase and sales contract; before May 18, complete the signing of the purchase and sales agreement; and officially implement the fourth batch of national organization drug procurement results in Ningxia on May 20.
Jiangsu
On March 19, the Jiangsu Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement Results", which officially determined the launch time of the fourth batch of nationally selected results in Jiangsu Province.
According to the notice, all public medical institutions and military medical institutions in Jiangsu Province will start to implement the fourth batch of procurement products announced by the National Procurement and the results of the selection from April 27, 2021.
Liaoning
On March 2, the Liaoning Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in Preparations for the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement (Liaoning) Results".
From 0:00 on May 1st, Liaoning Province will implement the fourth batch of national Collect the results of the selection in Liaoning.
From 0:00 on May 1st, Liaoning Province will implement the fourth batch of national Collect the results of the selection in Liaoning.
According to the schedule of Liaoning Province:
Before April 20th, the municipal medical insurance bureaus will organize medical institutions to complete the signing of bulk purchase contracts for drug production (business) enterprises.
Before April 20th, the medical insurance agencies of each city shall calculate the prepaid working capital according to the agreed purchase amount of the medical institution (the prepaid working capital shall be allocated to the medical institution in areas where the direct settlement of the medical insurance fund is not implemented).
Before April 30, the relevant selected drugs will be prepared in advance to the relevant medical institutions.
21 provinces and cities issued the fourth batch of national procurement notices
According to Cyberlan’s latest review, in addition to the above eight provinces, Yunnan, Anhui, Guangdong, Shaanxi, Hunan, Ningxia, Tibet, Sichuan, Hainan, Hubei, Shanghai, Gansu, Jiangxi, Tianjin, Jilin, Beijing, Qinghai, Inner Mongolia, The 21 provinces and cities of Fujian, Xinjiang, and Guangxi have also issued relevant notices on the results of the fourth batch of national selection.
According to official sources, the fourth batch of centralized procurement of drugs is expected to land around May.
At present, 29 provinces and cities have issued relevant documents on the implementation of the fourth batch of national procurement.
It is believed that as May approaches, the remaining regions will also The announcement of the fourth batch of relevant announcements on the results of the national procurement selection.
At present, 29 provinces and cities have issued relevant documents on the implementation of the fourth batch of national procurement.
It is believed that as May approaches, the remaining regions will also The announcement of the fourth batch of relevant announcements on the results of the national procurement selection.
At present, the notices in the 8 provinces and cities of Inner Mongolia, Beijing, Fujian, Xinjiang, Guangxi, Tibet, Qinghai, and Yunnan are still within the statute of limitations.
Although these notices do not specify the execution time of the results, the online procurement and contract signing before the results are implemented The work has been arranged, and I believe that the final landing is close at hand.
Although these notices do not specify the execution time of the results, the online procurement and contract signing before the results are implemented The work has been arranged, and I believe that the final landing is close at hand.
Inner Mongolia
On April 9, the Inner Mongolia Autonomous Region Pharmaceutical Purchasing Network issued the "Notice on Publicizing the Review Results of Inner Mongolia Autonomous Region's Drug Centralized Online Work (Fourth Batch)", and announced the fourth batch of drug information review results.
The publicity period is April 2021.
9th-April 15th.
The publicity period is April 2021.
9th-April 15th.
According to the notice, the participating companies log in [Inner Mongolia Autonomous Region Drug Centralized Procurement System]-[Assessment System]-[Audit Result Disclosure List] to view relevant drug information audit results with their username and password.
Beijing
On April 9, Beijing Municipal Pharmaceutical Centralized Purchasing Service Center issued the "Notice on Carrying out the Supply List of Selected Varieties in the Fourth Batch of State-Organized Pharmaceutical Centralized Purchasing and Confirmation of Distributors"
In accordance with Beijing's implementation of the fourth batch of nationally organized drug procurement and use related requirements, Beijing will soon carry out the supply list of relevant selected varieties and the confirmation of distributors.
The fourth batch of state-organized pharmaceutical manufacturing companies that use centralized procurement of drugs and use the selected varieties in Beijing will log in to the Beijing Pharmaceutical Sunshine Procurement Platform and perform confirmation operations in accordance with the relevant operating manuals.
Manufacturers of selected products need to complete the confirmation of supply products and distributors in the system on April 9-15, 2021.
They belong to the fourth batch of nationally announced drugs to organize centralized procurement of drugs.
The selected specifications and packaging products of national drugs are required products.
.
They belong to the fourth batch of nationally announced drugs to organize centralized procurement of drugs.
The selected specifications and packaging products of national drugs are required products.
.
Manufacturers should log in to the Sunshine Pharmaceuticals Purchasing Platform in a timely manner, and complete the signing and termination of the contract with the delivery company in accordance with the confirmed supply products.
Manufacturers should truthfully confirm the supply of products and distributors, and ensure that they can supply Beijing medical institutions in a timely and sufficient manner through confirmed distributors.
For products with unconfirmed distributors that expire, the platform will treat them as non-supplied products and suspend purchases.
For products with unconfirmed distributors that expire, the platform will treat them as non-supplied products and suspend purchases.
After this confirmation, the Beijing Municipal Pharmaceutical Centralized Purchasing Service Center will publicize the selected product supply list and the results of the distributors confirmed by each manufacturer, so that each medical institution can choose to purchase.
Fujian
On April 8, the Fujian Medical Insurance Bureau issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Related Drugs Online" The relevant matters are notified as follows:
After the fourth batch of national-organized centralized drug procurement is selected, the drugs in the list of products supplied by Fujian will start to declare their products from April 9 to 13, 2021.
The notice gives different declaration paths for drugs that have been listed on the Internet in Fujian Province and those that have not been listed on the Internet in Fujian Province:
(1) For drugs that have been listed on the Internet catalogue in Fujian Province, the online maintenance and price confirmation are carried out through the "Internet status and price dynamic adjustment" module of the Fujian Pharmaceutical Machinery Joint Price-Limiting Sunshine Procurement Platform.
(2) For drugs that are not listed on the Fujian Provincial Internet Catalog, fill in and upload relevant supporting documents through the "Enterprise Basic Information Application" and "Product Basic Information Application" modules of the Fujian Pharmaceutical Equipment Joint Price-Limiting Sunshine Procurement Platform.
After the basic information is declared, Apply for listing and price declaration through the platform "Network Link Status and Price Dynamic Adjustment" module.
After the basic information is declared, Apply for listing and price declaration through the platform "Network Link Status and Price Dynamic Adjustment" module.
Xinjiang
On April 6, the drug procurement management platform for medical institutions in Xinjiang issued the "Notice on Starting the Preparation Work for the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected in the Internet".
The notice requires that among the selected products, those manufacturing and operating companies that are not registered on the drug procurement management platform of Xinjiang medical institutions shall, in accordance with the requirements of the "Notice on the Implementation of the Work Related to the Implementation of the Autonomous Region’s Drug Price and Recruitment Credit Evaluation System," After the platform uploads the letter of commitment to keep promises, it then submits the materials to apply for the enterprise user name, and finally applies for the digital certificate.
From the date of publication of the notice, relevant companies can begin relevant operations.
From the date of publication of the notice, relevant companies can begin relevant operations.
All relevant drug manufacturers and operating (distributing) companies can log in to the "Autonomous Region Medical Institution Drug Centralized Purchase Transaction System" from April 6 to start maintaining and confirming the drug distribution relationship.
The relevant drug manufacturers and operating (distribution) companies are requested to complete the determination of the distribution relationship of the selected drugs before April 15, 2021.
The Autonomous Region Medical Institutions’ Drug Centralized Procurement Transaction System will start the tripartite contract function for selected drugs on April 20.
Medical institutions, drug manufacturers, and business (distribution) companies are requested to complete the tripartite contract as soon as possible so that online transactions can be carried out on time.
.
Medical institutions, drug manufacturers, and business (distribution) companies are requested to complete the tripartite contract as soon as possible so that online transactions can be carried out on time.
.
Guangxi
On April 6, the procurement service platform of Guangxi Pharmaceutical Group issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Guangxi Selected Drugs".
The fourth batch of national-organized centralized drug procurement in Guangxi selected drugs in accordance with the "National Drug Centralization List of products to be supplied after selection in procurement)" The selected price and specifications and packaging information are directly posted online.
The fourth batch of national-organized centralized drug procurement in Guangxi selected drugs in accordance with the "National Drug Centralization List of products to be supplied after selection in procurement)" The selected price and specifications and packaging information are directly posted online.
Related pharmaceutical companies log on to the Guangxi Pharmaceutical Group Procurement Service Platform before April 12, maintain corporate information, product information, and price information in accordance with platform requirements, complete information filling and upload qualification documents.
At the same time, relevant pharmaceutical manufacturers are requested to independently select distribution companies with distribution capabilities and good reputation on the platform to prepare for the establishment of distribution relationships.
Tibet
The Tibet Autonomous Region Drug Purchasing Service Management Center issued the "Notice on Convening the Fourth Batch of National Organizations for Centralized Drug Purchasing and the "Six Provinces and Two Districts" Inter-provincial Union Drug Centralized Procurement Work Meeting", stating that the fourth batch of national organizations is planned to be held in Lhasa.
The deployment meeting for centralized drug procurement and the implementation of selected products in the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Meeting time: April 13, 2021, from 10:00 to 13:00.
The deployment meeting for centralized drug procurement and the implementation of selected products in the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Meeting time: April 13, 2021, from 10:00 to 13:00.
At that time, the meeting will make specific arrangements for the fourth batch of national centralized drug procurement and the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Qinghai
On April 2, the Qinghai Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Related to the Internet", which clarified that the same category of drugs has passed the consistency evaluation of more than 3 (including 3), no more listing of generic drugs that have not passed the consistency evaluation.
Selected and non-selected drugs that have won the bid (linked to the Internet) in Qinghai Province, and related companies have registered for centralized trading of drugs and medical consumables-"Data reporting in the drug trading system-the fourth batch of national selected drugs price declaration and the fourth batch of national non-selected drugs The price declaration module carries out price declaration separately.
For products that are not listed on the Qinghai Province, relevant companies log on to the Qinghai Province Drug and Medical Consumables Centralized Procurement Network to apply for the fourth batch of nationally organized drugs for centralized procurement of selected drugs and non-selected drugs.
(1) Corporate information maintenance and price declaration time: April 2, 2021 to April 12, 2021.
(2) Confirmation time of the selected drug distribution relationship: before 18:00 on April 15, 2021.
(3) The application information of non-selected drugs will be publicized and will be posted on the Internet if they meet the requirements, and the time for the selection and confirmation of the distribution relationship will be notified separately.
Yunnan
On March 26, the Yunnan Provincial Drug Centralized Procurement Platform issued the "Notice on the Issues Concerning the Online Transactions of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected" clarified that the results of the fourth batch of nationally organized centralized drug procurement in Yunnan correspond to the list of supply varieties For the drugs with the remarks "sample registration required", the sample registration work will begin immediately.
Enterprises are required to complete the sample registration according to the prescribed procedures.
Enterprises are required to complete the sample registration according to the prescribed procedures.
After the enterprise completes the sample filing, before 17:00 on April 15, 2021 (except statutory holidays), the Yunnan Provincial Drug Administration will stamp the "Yunnan Province Essential Drugs Bid Sample Recording Form" and the "Statutory Representative Authorization Letter", the original scanned and sent to the e-mail: ynsypjzcgpt@163.
com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
The final online transaction time will be notified separately.
A few days ago, relevant industry media reported that for the fifth batch of national sources, the current varieties have met the start-up requirements, and the fifth batch of national sources is in the pipeline.
According to past laws, as the fourth batch of national procurement is implemented nationwide, a new round of centralized procurement may be on the way.
According to past laws, as the fourth batch of national procurement is implemented nationwide, a new round of centralized procurement may be on the way.
Medical Network News on April 12
The fourth batch of national procurement, 8 provinces specify the implementation time
The fourth batch of national procurement, 8 provinces specify the implementation time According to Cyberlan's analysis on April 10, 8 provinces of Liaoning, Jiangsu, Ningxia, Henan, Shanxi, Zhejiang, Guizhou, and Heilongjiang have determined the implementation time of the fourth batch of national procurement.
Guizhou
Guizhou On April 9, the Guizhou Province Pharmaceutical Centralized Procurement Platform issued the "Guizhou Province’s Notice on Implementing the Fourth Batch of National Organizations for Centralized Drug Procurement Work", clarifying that Guizhou Province will implement the fourth batch of national procurement from April 30, 2021.
Winning result.
Medicine, medicine, medicineWinning result.
It is worth noting that Guizhou Province proposed that 40 mg of pantoprazole sodium for injection will be implemented according to the results of the five provinces and cities, and the national election results will be implemented the following year.
The selected price of this product, Jiangsu Aosaikang Pharmaceutical Co.
, Ltd.
and Yangtze River Pharmaceutical Group Co.
, Ltd.
, selected in five provinces and cities, will be adjusted and implemented according to the national selected price from April 30.
The selected price of this product, Jiangsu Aosaikang Pharmaceutical Co.
, Ltd.
and Yangtze River Pharmaceutical Group Co.
, Ltd.
, selected in five provinces and cities, will be adjusted and implemented according to the national selected price from April 30.
Regarding the conflicts between the centralized procurement of inter-provincial alliances and the centralized procurement of drugs organized by the state, the results of the selection, and the prices of the selection, Guizhou Province has given the above-mentioned measures.
Guizhou Province requires selected companies to establish distribution relationships on the platform in advance, and medical institutions will place orders for purchases from April 30th.
In order to ensure the supply of selected products, the selected companies independently entrust companies with excellent distribution performance to establish distribution relationships.
There are no less than 2 cities (states), and the distribution area can cover all medical institutions participating in mass procurement.
In order to ensure the supply of selected products, the selected companies independently entrust companies with excellent distribution performance to establish distribution relationships.
There are no less than 2 cities (states), and the distribution area can cover all medical institutions participating in mass procurement.
Heilongjiang
Heilongjiang On April 8, the Heilongjiang Provincial Drug Centralized Procurement Network issued the "Notice on Doing a Good Job in the Implementation of the National and Inter-provincial Alliance Drug Centralized Procurement of Drugs".
It is clear that the fourth batch of nationally organized drug procurement in Heilongjiang will be selected from May 1, 2021.
It will be implemented throughout the province starting from today.
It is clear that the fourth batch of nationally organized drug procurement in Heilongjiang will be selected from May 1, 2021.
It will be implemented throughout the province starting from today.
The notice requires that all municipal (prefecture) medical insurance bureaus should organize the contract signing between public medical institutions in their jurisdictions and selected manufacturing enterprises (distributors with distribution qualifications independently selected by the selected manufacturing enterprises), and sign purchase and sales contracts in a manner recognized by both parties.
To confirm the purchase volume and total purchase amount, each municipal (prefecture) medical insurance bureau shall supervise and urge relevant medical institutions to complete the contract purchase quantity and proportion within the purchase cycle, and encourage medical institutions to more accurately submit basic data for the purchase of quantities.
To confirm the purchase volume and total purchase amount, each municipal (prefecture) medical insurance bureau shall supervise and urge relevant medical institutions to complete the contract purchase quantity and proportion within the purchase cycle, and encourage medical institutions to more accurately submit basic data for the purchase of quantities.
Zhejiang
Zhejiang On April 2, the Zhejiang Medical Insurance Bureau issued the "Announcement on the Implementation of the Results of the Fourth Batch of National Organizations for Centralized Procurement of Drugs" officially announced the implementation time of the fourth batch of national procurement results.
，2021428，、，。
46，pharmnet.
com.
cn/news/yyzb/" target="_blank">《（）》，。
pharmnet. com.
cn/news/yyzb/" target="_blank">《（）》，。
com.
cn/news/yyzb/" target="_blank">pharmnet.
com.
cn/news/yyzb/" target="_blank">
，（）2021428。420，。
：
： ，，50（；1；），（），（CA）“”，，。
，。。202147413。
。。，，。
。202149415。2021499：0041516：00。
330，《》，202151。
、，3-5，。
326，《》，2021430。
416、。、，。
423、、，，。
426，。，430。
325，《》，，2021520。
420CA，；518，；520。
319，《》，。
，，2021427。
32，《（）》，51，。
：
： 420，（）。
420，，（，）。
430，。
21
21 ，8，、、、、、、、、、、、、、、、、、、、、21。
，5，29，5，。
、、、、、、、8，，、，。
49，《（）》，，202149-415。
，【】—【】—【】。
49，《》
，。
，，。
202149-15，。
，。
，、。，，。
，，。
48，《》，，：
20214913，。
：
（），“”。
（），“”、“”，，“”。
On April 6, the drug procurement management platform for medical institutions in Xinjiang issued the "Notice on Starting the Preparation Work for the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected in the Internet".
The notice requires that among the selected products, those manufacturing and operating companies that are not registered on the drug procurement management platform of Xinjiang medical institutions shall, in accordance with the requirements of the "Notice on the Implementation of the Work Related to the Implementation of the Autonomous Region’s Drug Price and Recruitment Credit Evaluation System," After the platform uploads the letter of commitment to keep promises, it then submits the materials to apply for the enterprise user name, and finally applies for the digital certificate.
From the date of publication of the notice, relevant companies can begin relevant operations.
From the date of publication of the notice, relevant companies can begin relevant operations.
All relevant drug manufacturers and operating (distributing) companies can log in to the "Autonomous Region Medical Institution Drug Centralized Purchase Transaction System" from April 6 to start maintaining and confirming the drug distribution relationship.
The relevant drug manufacturers and operating (distribution) companies are requested to complete the determination of the distribution relationship of the selected drugs before April 15, 2021.
The Autonomous Region Medical Institutions’ Drug Centralized Procurement Transaction System will start the tripartite contract function for selected drugs on April 20.
Medical institutions, drug manufacturers, and business (distribution) companies are requested to complete the tripartite contract as soon as possible so that online transactions can be carried out on time.
.
Medical institutions, drug manufacturers, and business (distribution) companies are requested to complete the tripartite contract as soon as possible so that online transactions can be carried out on time.
.
Guangxi
Guangxi On April 6, the procurement service platform of Guangxi Pharmaceutical Group issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Guangxi Selected Drugs".
The fourth batch of national-organized centralized drug procurement in Guangxi selected drugs in accordance with the "National Drug Centralization List of products to be supplied after selection in procurement)" The selected price and specifications and packaging information are directly posted online.
The fourth batch of national-organized centralized drug procurement in Guangxi selected drugs in accordance with the "National Drug Centralization List of products to be supplied after selection in procurement)" The selected price and specifications and packaging information are directly posted online.
Related pharmaceutical companies log on to the Guangxi Pharmaceutical Group Procurement Service Platform before April 12, maintain corporate information, product information, and price information in accordance with platform requirements, complete information filling and upload qualification documents.
At the same time, relevant pharmaceutical manufacturers are requested to independently select distribution companies with distribution capabilities and good reputation on the platform to prepare for the establishment of distribution relationships.
Tibet
Tibet The Tibet Autonomous Region Drug Purchasing Service Management Center issued the "Notice on Convening the Fourth Batch of National Organizations for Centralized Drug Purchasing and the "Six Provinces and Two Districts" Inter-provincial Union Drug Centralized Procurement Work Meeting", stating that the fourth batch of national organizations is planned to be held in Lhasa.
The deployment meeting for centralized drug procurement and the implementation of selected products in the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Meeting time: April 13, 2021, from 10:00 to 13:00.
The deployment meeting for centralized drug procurement and the implementation of selected products in the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Meeting time: April 13, 2021, from 10:00 to 13:00.
At that time, the meeting will make specific arrangements for the fourth batch of national centralized drug procurement and the "six provinces and two districts" inter-provincial alliance drug centralized procurement.
Qinghai
Qinghai On April 2, the Qinghai Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Related to the Internet", which clarified that the same category of drugs has passed the consistency evaluation of more than 3 (including 3), no more listing of generic drugs that have not passed the consistency evaluation.
Selected and non-selected drugs that have won the bid (linked to the Internet) in Qinghai Province, and related companies have registered for centralized trading of drugs and medical consumables-"Data reporting in the drug trading system-the fourth batch of national selected drugs price declaration and the fourth batch of national non-selected drugs The price declaration module carries out price declaration separately.
For products that are not listed on the Qinghai Province, relevant companies log on to the Qinghai Province Drug and Medical Consumables Centralized Procurement Network to apply for the fourth batch of nationally organized drugs for centralized procurement of selected drugs and non-selected drugs.
(1) Corporate information maintenance and price declaration time: April 2, 2021 to April 12, 2021.
(2) Confirmation time of the selected drug distribution relationship: before 18:00 on April 15, 2021.
(3) The application information of non-selected drugs will be publicized and will be posted on the Internet if they meet the requirements, and the time for the selection and confirmation of the distribution relationship will be notified separately.
Yunnan
Yunnan On March 26, the Yunnan Provincial Drug Centralized Procurement Platform issued the "Notice on the Issues Concerning the Online Transactions of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected" clarified that the results of the fourth batch of nationally organized centralized drug procurement in Yunnan correspond to the list of supply varieties For the drugs with the remarks "sample registration required", the sample registration work will begin immediately.
Enterprises are required to complete the sample registration according to the prescribed procedures.
Enterprises are required to complete the sample registration according to the prescribed procedures.
After the enterprise completes the sample filing, before 17:00 on April 15, 2021 (except statutory holidays), the Yunnan Provincial Drug Administration will stamp the "Yunnan Province Essential Drugs Bid Sample Recording Form" and the "Statutory Representative Authorization Letter", the original scanned and sent to the e-mail: ynsypjzcgpt@163.
com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
The final online transaction time will be notified separately.
A few days ago, relevant industry media reported that for the fifth batch of national sources, the current varieties have met the start-up requirements, and the fifth batch of national sources is in the pipeline.
According to past laws, as the fourth batch of national procurement is implemented nationwide, a new round of centralized procurement may be on the way.
According to past laws, as the fourth batch of national procurement is implemented nationwide, a new round of centralized procurement may be on the way.
